News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer. – Agenus
Photo taken from: Agenus/LinkedIn
Oct 11, 2023, 22:39

Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer. – Agenus

Agenus, made the following post on LinkedIn:

“Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer.”

For details click here.
Source: Agenus/LinkedIn

Agenus Biotechnology cancer OncoDaily Oncology Research
Special Coverage
Voices
Sep 1, 2025, 14:01
Angela Mastronuzzi: Today begins Childhood Cancer Awareness Month
Voices
Sep 1, 2025, 13:59
Cynthia Jordan: Young Breast Cancer Patients Deserve Fertility Conversations
Societies
Sep 1, 2025, 13:56
IASLC Showcases Diverse Educational Opportunities at WCLC25
Voices
Sep 1, 2025, 13:51
Carmen Uscatu: How 'Give Life' is Overcoming Complexity in Childhood Cancer Care
Opinion
Sep 1, 2025, 13:43
Malignant Hematology Mentorship Program is now open for applications - The American Society of Hematology
Voices
Sep 1, 2025, 13:40
Breaking Down Stigma: Anubha Varma's Story of Cancer Awareness in Diverse Communities
Science
Sep 1, 2025, 13:26
Amol Akhade: ACROSS-2 vs FLAURA2
Science
Sep 1, 2025, 13:19
Andrea Boutros: Can We Spare Surgery and Radiation for Some CSCC Patients?
Science
Sep 1, 2025, 13:07
Dani Castillo: Excited to Share New Publication on Multi-Analyte Liquid Biopsy for Esophageal Cancer
Voices
Sep 1, 2025, 12:48
Xiuning Le: Ready to Debate the brilliant Dr. Tom Newsom-Davis
Science
Sep 1, 2025, 12:18
Erika Hamilton: Capecitabine Improves Outcomes for Residual Disease Beyond CREATE-X Trial
Science
Sep 1, 2025, 12:07
Christopher Steer: A Major Step to Enable Person-Centred, Age-Friendly Cancer Care